Bio-Matrix Scientific Group, Inc. Installs Computype's Secured Blood Bank Labeling and Identification Systems for its Adult Stem Cell Processing and Cryogenic Banking Laboratories biz.yahoo.com
Wednesday May 7, 9:01 am ET SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group Inc. (OTCBB:BMSN - News), a biotechnology company focused on adult stem cell processing and cryogenic storage, announced today that it is installing blood bank labeling systems manufactured by Computype in all of Bio-Matrix’ laboratories.
A major emphasis of Bio-Matrix' Quality Systems prior to acceptance of human stem cell specimens has been the inclusion of appropriate systems and controls to ensure the traceability of any individual donor specimen from the registration process, collection procedure, processing and storage and possible future cellular transplant. Bio-Matrix has selected Computype, a leader in the manufacture of bar code labels, to implement its bar-coded label and identification system that complies with the Food and Drug Administration's “Universal Labeling Guidelines.”
“We are informed that over the last thirty years Computype has produced more bar code labels for use within the international blood bank community than perhaps any other company,” stated a Bio-Matrix spokesperson, “and that is the type of industry accepted reliability we are seeking when sourcing for our company.”
Bio-Matrix intends to further strengthen its labeling system from using RFID tags that will provide enhanced traceability of specimens as well as providing "real time" tissue process information. The safety of all specimens for future cellular therapies is of paramount importance in Bio-Matrix’ long-term cellular storage business.
About Bio-Matrix Scientific Group
Bio-Matrix Scientific Group Inc. (www.BMSN.us) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix’ new 15,000 sq. ft. state-of-the-art facility, located in the heart of San Diego’s biotechnology corridor, will house Bio-Matrix’ two secure Cryogenic Stem Cell Bank, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories. |